Graft-vs-host disease after non-myeloablative hematopoietic cell transplantation (Q36234484)

12 August 2017

1 reference

title

Graft-vs-host disease after non-myeloablative hematopoietic cell transplantation (English)

1 reference

12 August 2017

2

Rainer Storb

1 reference

12 August 2017

1

Marco Mielcarek

1 reference

12 August 2017

1 September 2005

1 reference

12 August 2017

1 reference

12 August 2017

46

1 reference

12 August 2017

9

1 reference

12 August 2017

1251-1260

1 reference

Non-myeloablative hematopoietic cell transplantation as immunotherapy for hematologic malignancies

12 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F10428190500125754

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500125754

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500125754

Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500125754

Allografting after nonmyeloablative conditioning as a treatment after a failed conventional hematopoietic cell transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500125754

Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500125754

Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500125754

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induc

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500125754

Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500125754

Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500125754

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500125754

Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500125754

Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500125754

Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500125754

Prognostic relevance of 'early-onset' graft-versus-host disease following non-myeloablative haematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500125754

Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500125754

10.1080/10428190500125754

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

16109601